DNA vaccine-encoded glycoprotein B of HSV-1 fails to protect chronic morphine-treated mice against HSV-1 challenge

Comparative Immunology, Microbiology and Infectious Diseases

Volumn 30, Issue 2, 2007, Pages 71-80

  Jamali, Abbas ^a   Roostaee, Mohammad H ^a   Soleimanjahi, Hoorieh ^a   Ghaderi Pakdel, Firouz ^b   Bamdad, Taravat ^a  

^a TARBIAT MODARES UNIVERSITY   (Iran)

^b URMIA UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

DNA vaccine; Herpes simplex virus; Morphine; Vaccin d'AND; Virus de simplex d'herp s

Indexed keywords

DNA VACCINE; GLYCOPROTEIN B; LIVE VACCINE; MORPHINE; VIRUS ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ARTICLE; BAGG ALBINO MOUSE; CONTROLLED STUDY; DNA IMMUNIZATION; DRUG EXPOSURE; DRUG SAFETY; FEMALE; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; IMMUNE DEFICIENCY; IMMUNE RESPONSE; INFECTION SENSITIVITY; MOUSE; NONHUMAN;

ANALGESICS, OPIOID; ANIMALS; ANTIBODIES, VIRAL; CERCOPITHECUS AETHIOPS; FEMALE; GLYCOPROTEINS; HERPES SIMPLEX; HERPES SIMPLEX VIRUS VACCINES; HERPESVIRUS 1, HUMAN; HUMANS; HYPERSENSITIVITY, DELAYED; IMMUNOCOMPROMISED HOST; MICE; MICE, INBRED BALB C; MORPHINE; RANDOM ALLOCATION; VACCINES, DNA; VERO CELLS; VIRAL PROTEINS;

ANIMALIA; HERPES; HUMAN HERPESVIRUS 1; MUS; SIMPLEXVIRUS;

EID: 33846487911     PISSN: 01479571     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cimid.2006.10.002     Document Type: Article

References (31)

1. Vallejo R., Leon-Casasola O., and Benyamin R. Opioid therapy and immunosuppression. Am J Ther 11 (2004) 354-356
2. Pacifici R., Carlo S., Bacosia A., Pichini S., and Zuccaro P. Pharmacokinetics and cytokine production in heroin and morphine treated mice. Int J Immunopharmacol 22 (2000) 614-663
3. Bryant H.U., and Roundebush R.E. Suppressive effects of morphinepellet implants on in vivo parameters of immune function. J Pharmacol Exp Ther 255 (1990) 410-415
4. Suzuki S., Chuang A., Chuang L., Doi R., and Chuang R. Morphine promotes simian acquired immunodeficiency syndrome virus replication in monkey peripheral mononuclear cells: induction of CC chemokine receptor 5 expression for virus entry. J Infect Dis 185 (2002) 1826-1829
5. Coussons-Read M., Daniels M., and Gilmour M. Morphine alters the immune response to influenza virus infection in Lewis rats. Adv Exp Med Biol 437 (1998) 73-82
6. Friedman H., Newton C., and Klein T.W. Microbial infection, immunodulation, and drugs of abuse. Clin Microbial Rev 16 (2003) 209-219
7. Donnelly J.J., Ulmer J.B., Shiver J.W., and Liu M.A. DNA vaccines. Annu Rev Immunol 15 (1997) 617-648
8. Chattergoon M., Boyer J., and Weiner D.B. Genetic immunization: a new era in vaccines and immune therapeutics. FASEB J 11 (1997) 753-763
9. Giese M. DNA-antiviral vaccines: new development and approaches-a review. Virus Genes 17 (1998) 211-232
10. Roizman B, Knipe M. Herpes simplex virus and their replication. In: Fields virology, vol. 12, 4th ed. Philadelphia, PA, Baltimore, MD: Lippincott, Williams & Wilkins; 2001. p. 2391-510.
11. Logan W.S., Tindal J.P., and Elson M.L. Chronic cutaneus herpes simplex. Arch Dermatol 103 (1971) 606-614
12. Muller S.A., Hermann F.C., and Winkelman R.K. Herpes simplex infections in hematologic malignancies. Am J Med 52 (1972) 102-114
13. Whitly R., and Roizman B. Herpes simplex virus infections. Lancet 357 (2001) 1513-1518
14. Bernstein I.D., and Stanbery L.R. Herpes simplex virus vaccines. Vaccine 17 (1999) 1681-1689
15. Soleimanjahi H., Roostaee M.H., Rasaee M.J., Mahboodi F., and Bamdad T. Immunogenecity and efficacy of baculovirus-derived glycoprotein D of herpes simplex virus type-1 in mice. Arch Razi Ins 55 (2003) 19-28
16. Bamdad T., Roostaee M.H., Sadeghizadeh M., Mahboudi F., Kazemnejad A., and Soleimanjahi H. Immunogenicity and protective effect of a DNA construct encoding certain neutralizing epitopes of herpes simplex virus type-1 glycoprotein B. Folia Biol (Praha) 51 (2005) 109-113
17. Carpenter G.W., and Carr D.J. Pretreatment with β-funaltrexamince blocks morphine-mediated suppression of CTL activity in alloimmunized mice. Immunopharmacology 29 (1995) 129-140
18. Mc Carthy L., Wetzel M., Sliker J.K., Eisenstein T.K., and Rogers T.J. Opioids, opioid receptors, and the immune response. Drug Alcohol Depend 62 (2001) 111-123
19. Alonzo N.C., and Carr D.J. Morphine reduces mortality in mice following ocular infection with HSV-1. Immunopharmacology 41 (1999) 187-197
20. Sheridan P.A., and Moynihan J.A. Modulation of the innate immune response to HSV-1 following acute administration of morphine: role of hypothalamo-pituitary-adrenal axis. J Neuroimmunol 158 (2005) 145-152
21. Lioy D.T., Sheridan P.A., Hurley S.D., Walton J.R., Martin A.M., Olschowka J.A., et al. Acute morphine exposure potentiates the development of HSV-1-induced encephalitis. J Neuroimmunol 172 (2006) 9-17
22. Davies P.W., Vallejo M.C., Shannon K.T., Amortegui A.J., and Ramanathan S. Oral herpes simplex reactivation after intrathecal morphine: a prospective randomized trial in an obstetric population. Anesth Analg 100 (2005) 1472-1476
23. Boyle R.K. Herpes simplex labialis after epidural or parenteral morphine: a randomized prospective trial in an Australian obstetric population. Anesth Intensive Care 23 (1995) 433-437
24. Nass P.H., Elkins K.L., and Weir J.P. Protective immunity against herpes simplex virus generated by DNA vaccination compared to natural infection. Vaccine 19 (2001) 1538-1546
25. 4 T lymphocyte. J Immunol 155 (1995) 259-265
26. Bhargava H.N., Thomas P.T., Thorat S., and House R.V. Effect of morphine tolerance and abstinence on cellular immune function. Brain Res 642 (1994) 1-10
27. 2 effectors cells by modulating transcription factor GATA3 and T-bet. J Neuroimmunol 147 (2004) 78-81
28. Molitor T.W., Morilla A., Risdahl J.M., Murtaugh M.P., Chao C.C., and Peterson P.K. Chronic morphine administration impairs cell-mediated immuneresponses in swine. J Pharmacol Exp Ther 260 (1991) 581-586
29. Manickan E., Yu Z., Rouse R.J.D., Wire W.S., and Rouse B.T. Induction of protective immunity against herpes simplex virus with DNA encoding the immediate-early protein ICP27. Viral Immunol 8 (1995) 53-61
30. Holterman A.X., Rogers K., Edelmann K., Koelle D.M., Corey L., and Wilson C.B. An important role for major histocompatibility complex class I-restricted T cells, and a limited role for gamma interferon, in protection of mice against lethal herpes simplex virus infection. J Virol 73 (1999) 2058-2063
31. Cheng W.F., Chen L.K., Chen C.A., Chang M.C., Hsiao P.N., Su Y.N., et al. Chimeric DNA vaccine reverses morphine-induce immunosuppression and tumorigenesis. Mol Ther 13 (2006) 203-210